Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases

Author： Lima Breno R   Nussenblatt Robert B   Sen H Nida  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.7, 2013-07, pp. : 875-882

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Anti-inflammatory Drugs in the Treatment of Inflammatory Periodontal Diseases)

By  

Clinical Anti-Inflammatory & Anti-Allergy Drugs, Vol. 2, Iss. 1, 2015-04 ,pp. : 2-2

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics, Target Molecules, and Biological Anti-Rheumatic Drugs in Autoimmune/Chronic Inflammatory Rheumatic Diseases

By  

Current Pharmacogenomics, Vol. 4, Iss. 2, 2006-06 ,pp. : 105-111

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of Antipsychotic Drugs in Schizophrenia Treatment

By Tybura Piotr   Trzesniowska-Drukala Beata   Samochowiec Jerzy  

Current Psychopharmacology, Vol. 1, Iss. 1, 2012-02 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of Antipsychotic Drugs in Schizophrenia Treatment

By  

Current Psychopharmacology, Vol. 1, Iss. 1, 2012-02 ,pp. : 47-60

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Inflammatory Drugs in the Treatment of Neurodegenerative Diseases: Current State

By  

Current Pharmaceutical Design, Vol. 12, Iss. 27, 2006-09 ,pp. : 3509-3519

Bentham Science Publishers

Access to resources Recommend Favorite